Blum v. Anavex Life Sciences Corporation
Blum v. Anavex Life Sciences Corporation is a federal securities / commodities lawsuit filed on 03/13/2024 in the District Court, S.D. New York. The case was terminated on 06/20/2025.
- Court
- District Court, S.D. New York (S.D.N.Y.)
Official Court Website → - Assigned judge
- Colleen McMahon · 5,999 cases in index
- Docket number
- 1:24-cv-01910
- Cause
- 15:78m(a) Securities Exchange Act
15 U.S.C. § 78m - Nature of suit
- 850 Securities/Commodities
Alleged violations of federal securities or commodities laws. - Jurisdiction
- Federal Question
- Jury demand
- Plaintiff
- Date filed
- 03/13/2024
- Date terminated
- 06/20/2025
13,855 Securities / Commodities cases in this court are indexed here.
Parties
- plaintiff · Blum · 257 cases
- defendant · Anavex Life Sciences Corporation Pharmaceuticals & Biotechnology · 5 cases
Part of a Larger Litigation Pattern
This is one of 6 Securities / Commodities cases in our index naming Anavex Life Sciences Corporation — a possible mass-tort or coordinated-litigation cluster.
About Securities / Commodities Lawsuits
Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
Frequently Asked Questions
What is Blum v. Anavex Life Sciences Corporation?
Blum v. Anavex Life Sciences Corporation is a federal securities / commodities lawsuit filed on 03/13/2024 in the District Court, S.D. New York. The case was terminated on 06/20/2025. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What type of case is this?
It is classified as “Securities / Commodities” under the federal nature-of-suit system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What court is the case in?
The case is in the District Court, S.D. New York, docket number 1:24-cv-01910.
When was the case filed?
Blum v. Anavex Life Sciences Corporation was filed on 03/13/2024. It was terminated on 06/20/2025.
What law is the case brought under?
The docket lists the cause as 15 U.S.C. § 78m.
Other Cases Involving These Parties
Related Securities / Commodities Cases
Source: public U.S. federal court record (docket 68337947).